key: cord-0825488-7ld5lka6
authors: Winkels, Holger; Wolf, Dennis
title: Heterogeneity of T Cells in Atherosclerosis Defined by Single-Cell RNA-Sequencing and Cytometry by Time of Flight
date: 2020-12-03
journal: Arterioscler Thromb Vasc Biol
DOI: 10.1161/atvbaha.120.312137
sha: f27cd0eff4e0c2d7032b936ef8d700af68279a14
doc_id: 825488
cord_uid: 7ld5lka6

The infiltration and accumulation of pro- and anti-inflammatory leukocytes within the intimal layer of the arterial wall is a hallmark of developing and progressing atherosclerosis. While traditionally perceived as macrophage- and foam cell-dominated disease, it is now established that atherosclerosis is a partial autoimmune disease that involves the recognition of peptides from ApoB (apolipoprotein B), the core protein of LDL (low-density lipoprotein) cholesterol particles, by CD4(+) T-helper cells and autoantibodies against LDL and ApoB. Autoimmunity in the atherosclerotic plaque has long been understood as a pathogenic T-helper type-1 driven response with proinflammatory cytokine secretion. Recent developments in high-parametric cell immunophenotyping by mass cytometry, single-cell RNA-sequencing, and in tools exploring antigen-specificity have established the existence of several unforeseen layers of T-cell diversity with mixed T(H)1 and T regulatory cells transcriptional programs and unpredicted fates. These findings suggest that pathogenic ApoB-reactive T cells evolve from atheroprotective and immunosuppressive CD4(+) T regulatory cells that lose their protective properties over time. Here, we discuss T-cell heterogeneity in atherosclerosis with a focus on plasticity, antigen-specificity, exhaustion, maturation, tissue residency, and its potential use in clinical prediction.

T cells are regulators of adaptive immunity that are defined by surface expression of CD3 and the T-cell receptor (TCR) chains-α/β + or TCR-γ/δ + . Classical functions of α/β + T cells include protection from intracellular pathogens, larger parasites, elimination of tumor cells, and protection from autoimmune diseases. The role of γ/δ + T cells, which are outnumbered by α/β + T cells in tissues and circulation, will not be covered in this review. T cells develop in the thymus, where bone-marrow derived progenitors gradually develop into CD4 − CD8 − (double-negative [DN]) cells. At this stage, T cells divide into either α/β + or γ/δ + T cells. α/β + T cells transit into double-positive (DP) CD4 + CD8 + cells and eventually into naive CD4 + CD8 − T-helper cells or cytotoxic CD8 + CD4 − T cells. 1 CD4 + T cells recognize antigen-derived peptides presented on MHC (major histocompatibility complex)-II, whereas CD8 + T cells recognize peptides presented on MHC-I. The maturation of T cells is accompanied by recombinase activating genes-1 and -2 dependent rearrangement of TCR genes and the generation of a random, unique TCR on each T cell. This arrangement also results in autoreactive T cells that express a high-affinity TCR recognizing endogenously expressed self-peptides. Most of these self-reactive T cells are eliminated through a process termed negative selection, but this process does not eliminate all autoreactive CD4 + T cells. 2 Increasing evidence argues for the presence of CD4 + T cells recognizing peptides from ApoB (apolipoprotein B)-100, an established self-antigen in atherosclerosis. [3] [4] [5] The presentation of cognate peptides by antigen-presenting cells (APCs) on surface-expressed MHC-II induces the activation and differentiation of naive CD4 + T cells into functionally and phenotypically distinct T-helper (T H ) types that express exclusive sets of transcription factors (TFs) and cytokines. 6, 7 T H type 1 (T H 1) CD4 + T cells are proatherogenic and express the TF T-bet and the lead-cytokine IFN-γ (interferon-gamma). 8 In experimental mouse models, CD4 + T cells from atherosclerosis-prone apolipoproteindeficient (Apoe −/− ) mice home to the atherosclerotic aorta and secrete IFN-γ. 9, 10 The genetic deletion of T-bet or IFNγ reduces atherosclerosis markedly. 11, 12 T H 2 cells express GATA3 (GATA-binding protein 3) and IL (interleukin)-4, -5, -10, and -13 13 and may support atheroprogression or -protection. 14, 15 T H 17 cells express the lineage-defining TF RORγt (RAR-related orphan receptor) and the cytokines IL-17A, -17F, and -21. Their role in atherosclerosis is controversial. [16] [17] [18] [19] T H 9 cells are characterized by IL-9 secretion; treatment of Apoe −/− mice with IL-9 increases atherosclerosis, 20 but the overall role of T H 9 cells in atherosclerosis remains unknown. Follicular T helper cells (T FH ) express the transcription factor Bcl-6, the costimulatory molecule inducible T-cell costimulator and CXCR5 (C-X-C chemokine receptor type 5). 21 T FH are mostly found in germinal centers in secondary lymphoid organs where they provide help to B cells for immunoglobulin class switching. Emerging data suggest that T FH contribute to the proinflammatory response in atherosclerosis. 22, 23 T regulatory cells (T reg ), defined by expression of FoxP3 and IL-2 receptor (CD25), are immunosuppressive 24, 25 and prevent from atherosclerosis by multiple mechanisms, including secretion of IL-10 and TGF-β (transforming growth factor-β). 26, 27 The regulation of T regs in mouse and human atherosclerosis and the relationship to pathogenic T H -types has been controversial: fractions of FoxP3 + T regs decrease in murine atherosclerotic aortas and blood but increase in the spleen of the same animals. 28 A proportion of T regs in the aorta and in lymph nodes of mice seems to obtain a T H 1-like phenotype and expresses IFN-γ. 29 While numbers of T regs decrease during acute coronary syndromes in humans, [30] [31] [32] frequencies of blood T regs are higher in patients with angiographically documented atherosclerosis compared with healthy individuals. 5 Other studies have failed to establish that frequencies of blood T regs predict future myocardial infarction. 33 Traditional TF staining in mouse atherosclerotic aortas by intracellular flow cytometry (fluorescence-activated cell sorting) and a canonical gating strategy has suggested a mix of FoxP3 + (T reg ), RORγT + (T H 17), and T-bet + (T H 1) CD4 + T cells, 5, 29, [34] [35] [36] while the quantification of T H -associated surfaceexpressed chemokine-receptor patterns in humans suggests a predominant T H 1 and T H 2 phenotype. 8 37, 39, 41 Single-cell RNA sequencing (scRNA-seq), on the other hand, provides transcriptomes of single cells with an average of 1300 to 8000 genes per cell, which enables the detection of transcriptionally defined cell populations. The first application of scRNA-seq in atherosclerosis used a microfluidics-based platform for 96-well sorting that allowed to study only limited numbers of cells. 29 Today, technologies encapsulating up to 10 000 individual cells into oil droplets are commercially available (drop-sequencing). These have successfully been applied to atherosclerotic plaques from mice and humans. 39, 40, [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] A newer strategy enables the combination of single cell transcriptomes and cell surface expression of proteins detected by RNA-barcoded antibodies (cellular indexing of transcriptomes and epitopes by sequencing). 37, 53 In scRNA-seq based approaches, genes encoding for Cd3d or Cd3e can be used to identify T cells. In contrast to Cd8, Cd4-transcripts are only weakly expressed. The segregation of T-cell lineages by scRNAseq is challenging as the sensitivity to detect genes with low expression differs across technical pipelines: for example, the sensitivity of Smart-Seq2 is 2.5× higher compared with droplet-based sequencing by 10× Genomics 3' v.2. 54 Other technical challenges include gene dropouts caused by low RNA-expression, inefficient mRNA capture, and the stochastic, pulsatile nature of gene expression on a single-cell level. 55 Accordingly, cells positive for TF-coding and other genes at low expression are often sparse in scRNA-seq datasets. Even in the meta-analysis of several mouse datasets, expression of transcripts coding for T-bet and FoxP3 was rare and did not allow the identification of distinct T H 1 or T reg -clusters based on TFs alone. 47 Of note, all high-parametric tools require the mechanical disruption of tissue-resident cells by enzymatic digestion, which may lead to an underestimation of fragile cellular subsets, such as macrophages that populate up to 50% of the atherosclerotic plaque area based on imaging-or histology-based detection. 51, 56 Other technical requirements and limitations of CyTOF and scRNAseq have been reviewed recently. 57 An ongoing challenge remains to combine and integrate different datasets into one cellular atlas of atherosclerotic lesions with a unified nomenclature-an attempt recently undertaken in the first meta-analysis of mouse plaque-resident leukocytes. 47 Ultimately, novel immunophenotyping workflows may be combined with reagents to detect antigen-specific T H cells recognizing particular antigenic peptide laden MHC multimers labeled with fluorochromes. 58 Recently, we have demonstrated the existence of human and mouse ApoB-specific T H cells on a single-cell level by MHC-II tetramers 3, 5 and linked these to single-cell transcriptomes. 5 These technical developments helped to describe several novel layers of T-cell diversity in atherosclerosis with respect to spatial, temporal, phenotypic, antigen-specific, and transcriptional resolution that fundamentally differs from traditional discrimination and nomenclature of CD4 + T cells.

The presence of T cells in atherosclerotic plaques and the surrounding adventitial tissue has been first observed >30 years ago. In immunohistochemistry, CD4 + and CD8 + T cells accumulate in the shoulder region, the fibrous cap, and the intima of human atherosclerotic plaques as well as in adventitial tissue and account for up to ≈54% of all leukocytes in the shoulder region and ≈14% in the necrotic core. 59, 60 Contrastingly, (dying) macrophages dominate the necrotic core of plaques while B cells can only be found in relevant numbers in adventitial tissue. 39, 61 Recent immunophenotyping has validated the frequency of T cells in human atherosclerotic tissue, where T cells accounted for up to 65% of all leukocytes in CyTOF 37 and ≈52% in scRNAseq of human atherosclerotic plaques. 45 In mice, relative frequencies of T cells seem to be lower: in 2 studies, myeloid cells, T cells, B cells, and other smaller leukocyte subsets accounted each for ≈25% of all leukocytes in atherosclerotic aortas of Apoe −/− and Ldlr −/− mice, 39, 46 while another study found ≈6% of all leukocytes to be CD3 + TCR-β + T cells by CyTOF of atherosclerotic mouse aortas. 41 Notably, the approximate frequencies of parental leukocyte lineages seem to be consistent between conventional flow cytometry, CyTOF, and scRNA-seq in direct comparison. 37, 39 Besides potential differences related to the species, experimental protocols, and tested tissues (whole aorta versus plaque), the loss of particular cell types during tissue digestion may explain these inconsistent findings. 39, 46, 49 T cells are already detectable in adventitial tissue before the initiation of atherosclerosis: scRNA-seq of adventitial tissue demonstrated the existence of several T-cell subsets already in wild-type animals, 52 including 2 CD4 + subsets (clusters 12, 13 in the original dataset) and one CD8 + population (cluster 2 in the original dataset). 52 CD8 + , but not CD4 + , T cells were also found in the healthy arterial vessel of Apoe −/− mice, 39 whereas the highest numbers of CD4 + and CD8 + T cells were detected in atherosclerotic aortas. Notably, frequencies of T cells do not substantially differ between Apoe −/− and Ldlr −/− mice. 39, 46 In aggravated hypercholesterolemia, T-cell fractions in Apoe −/− and Ldlr −/− mice decrease, while total numbers increase, 39, 46 suggesting that the relative contribution of myeloid cells is increasing in advanced atherosclerosis. It is noteworthy that adventitial CD4 + T cells increase up to 10-fold in the proximity of atherosclerotic plaques. 62, 63 These may be partially located in artery tertiary lymphoid organs, structures that harbor significant numbers of CD4 + T cells, B cells, and other lymphocytes in aged mice. 61 It is therefore tempting to speculate how the spatial organization of T cells impacts on lesion development: while CD4 + T cells in atherosclerotic lesions could instruct and interact with other tissue-resident cells, specialized T FH cells in the adventitia could interact with highly concentrated B cells in artery tertiary lymphoid organs to induce immunoglobulin switching. Such side-specific cellular functions will have to be determined in future work, which could take advantage of the recent development of spatial single-cell transcriptomics that provide simultaneous gene expression and spatial information. 64 How circulating T cells correspond to T cells in the plaque has not been investigated in-depth, but a recent report applying cellular indexing of transcriptomes and epitopes by sequencing indicated that CD4 + and CD8 + effector-memory T cells 37 and T cells with a clonal restriction of the TCR 37,65 are overrepresented in atherosclerotic plaques in comparison with circulating T cells. These findings raise the question whether activated T cells primarily home to the plaque as recently suggested 9, 66, 67 or are generated in situ by local proliferation as a result of their interaction with local APCs. 9 Interestingly, 2 scRNA-seq reports have detected clusters of proliferating leukocytes that include T cells, 39, 47 arguing for in situ proliferation. Consistently, earlier evidence has suggested that DNA-synthesis, which typically occurs in proliferating cells, colocalizes with T cells. 68 It is therefore likely that both mechanisms-migration and in situ proliferation-contribute to the pool of lesional T cells.

Traditional immunophenotyping by fluorescence-activated cell sorting is per se limited by the usage of predefined sets of antibodies: in most studies, staining for CD62L and CD44, which discriminates between naive, effector-memory T cells, and central-memory T cells in the mouse, has been combined with intracellular expression of T H -defining TFs or cytokines for canonical gating and identification strategies. 2, 3, 5, 28, 69 Contrastingly, in most available scRNA-seq studies, T H -cell phenotypes were inferred from dimensionality reduction algorithms to detect clusters of cells with similar transcriptome without the bias of preselecting markers. Several T-cell populations that partially overlap have been identified by these screening approaches: 4 in Apoe −/−39 and in Ldlr −/− mice, 46 3 populations in adventitial cell preparations from Apoe −/− and wild-type mice, 52 and 5 clusters in an integrative analysis of published datasets. 47 The latter meta-analysis expands over the original studies by identifying one discrete population of T regs , which did not form a separate cluster in the original datasets. Some datasets contained a cluster with a proliferation and T-cell gene signature, albeit it is not clear whether this cluster contains other cell types as well. 39 The most consistent unique T-cell phenotypes across these studies include: a multilineage-committed (T reg -T H 1-T H 17-T H 2) Cxcr6expressing T cell (1), a naive T cell (2), a thymocyte-like T cell (3), and a Cd8 + cytotoxic T cell (4) . Phenotypes, frequencies, and proposed functions of these populations will be discussed in detail (Figure 1 ) in the following.

One cluster of CD8 + (Cd8b + ) cytotoxic T cells has been detected by scRNA-seq in atherosclerotic and healthy aortas but not in the adventitia, 39, 46, 52 suggesting CD8 + T cells are already present in the healthy intima or media of arteries. Genes differentially expressed by CD8 + T cells include Cd8a, Cd8b, Nkg7 (coding for natural killer cell granule protein 7), Ms4a4b, the CD20 homologue in T cells, Ccl5 (coding for C-C motif chemokine-ligand 5), Eomes (coding for the TF eomesodermin), and Gzmk (coding for Granzyme K). In scRNA-seq, 31% to 41% of lesional T cells were identified as cytotoxic T cells depending on tested genotypes and diets. 39, 46 The overall frequency of CD8 + T cells was confirmed by 2 CyTOF-studies of mouse aortas (≈30% of T cells). 39, 41 In humans, ≈30% of all leukocytes (and ≈50% of T cells) in plaques are CD8 + T cells. 37 In histology, the accumulation of CD8 + T cells seems to be particularly T Cells in Atherosclerosis 70 where they outnumber CD4 + T cells. 70, 71 The frequency of some CD8 + T-cell subsets found only in CyTOF correlates to TCRclonality in plaques, 37 suggesting their antigen-specific expansion. However, cognate antigens for CD8 + T cells remain to be determined, although HSP60 (heat shock protein 60) 72 and ApoB 73,74 are among the prime candidates. Generally, functions of CD8 + T cells include the removal of virus-infected and cancer cells. 75 The function of CD8 + T cells in atherosclerosis is ambivalent and stage dependent: antibody-mediated depletion of CD8 + T cells prevented atherosclerosis 76-78 by attenuating proinflammatory cytokine levels and myelopoiesis. 78 In established atherosclerosis, the depletion of CD8 + T cells was proatherogenic and reduced plaque stability, which was accompanied by elevated macrophage and T

Overview of the 4 major T-cell phenotypes identified by single-cell RNA-sequencing with key gene expression, frequencies, and regulated pathways during atherosclerosis progression. Gene signatures were retrieved by differentially expressed genes among all leukocytes across several studies. Frequencies of clusters were retrieved by an analysis of the original data set (*), 39 or estimations based on the original publication (**). 46 CD indicates chow diet-consuming mice; CTL, cytotoxic T-cell-mediated apoptosis; HFD, high-fat diet-consuming mice; IFN-γ, interferon-gamma; and WD, Western diet-consuming mice. ***Regulated pathways between CD and WD-fed mice were retrieved from study by Winkels et al. 39 Schematics adapted from "Smart Servier Medical Art. " cell reponses. 77, 79 Vaccination studies with HSP60 and ApoB peptides evidenced antiatherogenic effects by CD8 + T cells, [72] [73] [74] although no effect on atherosclerosis was observed in a humanized HLA mouse model. 80 Vaccination-induced atheroprotection was discussed to be a consequence of lower dendritic cell numbers in aortas, 74 enhanced macrophage death, and a blockade of T H 17 cell formation. 81 Atheroprotective properties of CD8 + T cells have been linked to CD8 + T regs , 82 a known subpopulation with immunosuppressive propensities. 83 It remains unclear how this functional dichotomy of CD8 + T cells corresponds to distinct subsets found in recent CyTOF studies. 39, 41 It is well possible, that some CD8 + T cells with distinct features occur uniquely in atherosclerotic lesions similar to recently discovered subsets of noncytotoxic CD8 + T cells in the tumor microenvironment. 84

A Cd28 + Ccr7 + cluster is detectable in the atherosclerotic aorta and the adventitia across several scRNA-seq data sets. 39, 46, 47, 52 The consensus genes for this cluster include Lef1, Dapl1, Tcf7, Sell, and Cd2 ( Figure 1 ). The chemokine receptor CCR7 (gene Ccr7) is expressed by naive and central memory cells and instrumental for lymph node homing. 85 The costimulatory molecule CD28 (gene Cd28) is required for effective T-cell co-stimulation by APCs and predominantly expressed by naive CD4 + T cells. 86 Although CD28 costimulation is not necessary for a memory recall-response, its therapeutic blockade reduces proatherogenic T H 1 responses. 87 Cd28 + Ccr7 + T cells account for ≈21% to 27% of all T cells. 39, 46 They become rarer and engage cell cycling genes and increase IL-7 signaling, 39 which supports survival, differentiation, and proliferation of T cells, 88 in more advanced atherosclerosis. This indicates that naive T cells either leave the plaque or transform into activated cell types represented by one of the other clusters. Because the core genes of this cluster are expressed by CD4 + and CD8 + cells, 89 this cluster likely contains naive CD4 + , CD8 + , and immature-like T cells. Notably, the naive (versus activated) gene signature seems to excel transcriptional differences between principal lineages (CD4 + versus CD8 + ). In CyTOF of human plaques, naive T cells did surprisingly not form a distinct cluster but were located within principal lineage clusters. 37 Numerically, naive T cells were relatively sparse in carotid plaques compared with blood, 37 corroborating the predominant activation of lesional T cells.

The most discrete cluster among non-Cd8 + T cells 39, 46, 47, 52 expresses the transcripts Cxcr6 coding for chemokine receptor CXCR6 (C-X-C chemokine receptor type 6) and Rora coding for the TF ROR-α, which is expressed by T H 17 cells and by a subsets of T regs . 90 Other core genes include Tmem176, Ramp3, Il7a, and Il1rl1 (Figure 1 ). This cluster was termed Il17 + Cxcr6 + in a recent meta-analysis. 47 It accounts for ≈21% of T cells in Ldlr −/− mice (cluster 8 in the original dataset 46 ) and ≈28 % in Apoe −/− mice (cluster 6 in the original dataset 39 ). CXCR6 is expressed by CD4 + T cells and natural killer T cells and guides T-cell homing. Global deficiency of CXCR6 reduces atherosclerosis and T-cell accumulation, 67 particularly of IL-17A-producing CD4 + T cells, 91 which is consistent with the concomitant expression of Rora in this subset. Accordingly, Tmem176a and Tmem176b are known to be overexpressed in T H 17 cells. 92 Yet, the gene signature of this cluster does not seem to be entirely consistent over different studies and comprises a strong T H 17 46 and/or an additional T H 2 gene signature. 39, 52 A selective analysis of scRNA-seq of filtered Cd4 + Cd8 − transcriptomes in the aorta showed the highest expression of Cxcr6 in clusters with a mixed T H 1/T H 2/T reg and an T H 1/T H 17 transcriptome. 5 These findings argue for a more complex phenotype and T H -type of this cluster. Traditionally, differentiation into T H -types is thought to occur unidirectional with only minimal overlap between distinct lineages. This concept was challenged by the discovery of CD4 + T cells co-expressing Foxp3, T-bet, and/ or RORγT in various (auto-) immune pathologies. 3, 10, 29, [93] [94] [95] Expression of >1 TF may argue for an enhanced plasticity of cells that are in transition into another T H -type. On the other hand, in the intestine, RORγt + T regs 96 and T H 1like T regs 97 represent unique lineages that control mucosal immunity. Depending on the condition, these mixed phenotypes result in pro-and/or anti-inflammatory properties. 2,3,10,29,93-95 Based on flow cytometry with canonical gating strategies and immunohistochemistry 22% to 30% of all CD4 + T cells are pathogenic T H 1 cells. 29, 35 T regs are less abundant in the aorta (≈5% to 30%). 98, 99 It should be noted that aortic T regs numbers decline in atherosclerotic mice over time. 28 Despite the contrasting role of T H 1 and T reg in atherosclerosis, 2 newer studies reported T H 1-like T regs co-expressing FoxP3, T-bet, IFN-γ, and CCR5 in lymph nodes and atherosclerotic aortas of Apoe −/− mice. 6, 10, 29 Fate mapping experiments with adoptive transfers established that these T H 1/T regs evolve from T regs . 5, 29 Consistently, in early scRNA-seq experiments, about 40% of all CD4 + T cells expressed T reg and T H 1 lineage genes. 29 In bulk RNA-seq, T H 1/T regs were transcriptionally closer to effector T cells than to T regs . 10 Functionally, these cells failed to fully suppress T effs and did not protect from atherosclerosis-despite the expression of FoxP3. 10, 29 Recent evidence has validated that 50% of all lesional CD4 + T cells express Cxcr6 and T H 1/T H 17/T reg / T FH genes simultaneously. 5 The coexpression of T H 1-and T H 17-associated genes has also been shown in CD4 + T cells isolated from human carotid plaques. 37 The loss of the T reg -defining TF FoxP3, particularly in antigen-specific T H cells, in the context of hypercholesterolemia and intracellular cholesterol accumulation seems to contribute to the switch of a T reg into an exT reg . 5, 22 In fact, in FoxP3-lineage-tracer mice, about 15% to 26% of all lesional CD4 + T cells stem from initial T regs . 5, 22 The exact molecular or cellular stimuli that cause a loss or an inactivity of FoxP3 in the setting of atherosclerosis are largely unknown. A solid line of evidence has identified inflammatory cues as crucial drivers of such T reg plasticity: Certain thymus-derived T regs undergo a reprogramming to effector-like T cells that depends on the downregulation of the transcription factor EOS encoded by Izkf4, an important co-repressor of Foxp3, 100 at sites of inflammation. This process seems to require IL-6, a proinflammatory cytokine that is elevated in atherosclerotic plaques. 101 IFN-γ, another proatherogenic key cytokine secreted by proinflammatory T H 1 cells 102 has the ability to promote T reg destabilization. 103 Under chronic cellular hypoxia as detected in atherosclerotic plaques, 104 Foxp3 becomes polyubiquinated and degraded in lysosomes. A key transcription factor induced by hypoxia is HIF-1α (hypoxia-inducible factor 1-alpha), which can bind to Foxp3 and directly cause its degradation while simultaneously stabilizing T H 17 gene expression. 105 In addition, it has been established that other proinflammatory cytokines or lipopolysaccharide promote Foxp3 degradation. 106 Likewise, several signaling pathways such as these involving the TF NFκB (nuclear factor κ-lightchain-enhancer), IRF (interferon regulatory factor)-4, Runx (Runt-related transcription factor), FoxP (Forkhead box protein P)-1, the nuclear protein DBC (deleted in breast cancer)-1, and serine/threonine-Pak (protein kinase)-2 (reviewed in study by Korn and Muschaweckh 107 ) as well as self-peptide induced TCR-signaling 108 have been linked to the plasticity of T regs . Altogether, these findings demonstrate a strong association of inflammation and T reg -instability, which sparks the yet unproven hypothesis that the multitude of factors that initiate and maintain atherosclerosis, such as local and systemic inflammation, LDL (low-density lipoprotein), vascular integrity and injury, immune cell accumulation, and antigen-recognition by T regs , favor a stage-and context-specific conversion of an initial protective into a pathogenic immune response (Figure 2 ). This process is likely gradual. Yet, it remains to be determined, which of the known signaling pathways and upstream mediators have a dominant role specifically in the context of atherosclerosis.

The definitive function of exT regs is controversial: while the mixed T reg /T H 17 phenotype may represent an intermediate stage toward a T H 1-dominated composite phenotype with a residual atheroprotective function, 5 a mixed T H 1-T reg aggravated atherosclerosis in a direct T-cell transfer in mice. 10, 29 On the other hand, T regs have the ability to acquire a T FH -like phenotype with enhanced IFN-γ secretion: a deletion of the T FH -transcription factor BCL (B-cell lymphoma protein)-6 seems to be atheroprotective, suggesting that the conversion of T regs into T FH may be proinflammatory. 22 However, in a transgenic mouse model, LDL and LDL-reactive CD4 + T cells converted into T FH cells, which protected from atherosclerosis though secretion of LDL-depleting IgG antibodies. 109 Thus, T FH cells could be pro-and anti-inflammatory, and this effect may likely dependent on antigen-specificity and tissue localization. Depending on the development of cluster algorithms in dimensionality reduction, it is foreseeable that even more distinct clusters with mixed phenotypes will be discovered. Conclusively, it should be assumed that the plasticity of T regs represent a gradual shift in phenotypes and effector functions triggered by a multitude of spatial and temporal events rather than a singular event that switches a cell from one to another definitive phenotype (Figure 2 ).

The existence of ApoB-specific T H cells has been indirectly inferred from a restricted (oligoclonal) TCR repertoire in the plaque 37 and of ApoB-specific T cells in lymph nodes, 5 cloning of oxLDL (oxidized low-density lipoprotein)-reactive CD4 + T cells from human and mouse atherosclerotic plaques 4,110 as well as from inflammatory cytokine secretion by CD4 + T cells restimulated with ApoB or LDL. 5, 65 Several fundamental characteristics of the autoreactive T-helper cell response have remained unanswered because tools to detect single ApoB-specific T cells (ApoB + ) were not available. To overcome these limitations, we have recently developed recombinant MHC-II multimers loaded with ApoB-peptides for the direct fluorochrome-based detection of single ApoB-reactive CD4 + T cells in mice and humans. 3, 5 These studies helped to define fractions, phenotypes, and dynamics of ApoB-specific cells in the atherosclerotic plaque and systemically: even in the absence of relevant atherosclerosis, we detected small fractions of ApoB + cells in mice and humans that transcriptionally and phenotypically resembled T regs . 3, 5 In disease, ApoB + cells gradually acquired a proinflammatory phenotype close to that of T H 1/T H 17/T FH cells (Figure 2 ). In single cell gene set enrichment analysis, about 50% of aortic CD4 + T cells (Cd4 + Cd8 − ) had a gene signature similar to that of ApoB + T cells. ApoB + but not ApoB neg T cells in lymph nodes expressed moderate to high levels of Cxcr6 in bulk RNA-seq, 5 suggesting that CXCR6 may serve as the homing receptor of antigen-specific CD4 + T cells. Although integrative analysis of this cellular subset and aortic T cells is not available, the gene signature strongly suggests that Cxcr6 + T cells in the plaque may represent T cells specific for an atherosclerosis-relevant antigen.

While the function of the heterogeneous population of ApoB + CD4 + T cells in atherogenesis has not been clarified completely, the distinctive function of individual T H -lineages has been validated extensively in the last decades. 6, 7 Notably, scRNA-seq of ApoB + T cells has 

In the course of atherosclerosis, regulatory T cells (T reg ) with an immunosuppressive and atheroprotective function lose their protective properties. In atherosclerotic plaques or lymph nodes, former T regs are characterized by an entire loss (exT reg ) or an inactivity of FoxP3 (T eff -like, CCR5 + T eff ). We propose that several classes of signals may induce such inactivity or loss of FoxP3. These include extrinsic signals (hypercholesterolemia, chronic low-grade inflammation, endothelial dysfunction, and plaque hypoxia) and overwhelming immune-signaling caused by repetitive (auto-) antigen presentation and costimulation. Intrinsic proinflammatory signaling events and epigenetic modifications may partially be promoted by such extrinsic stimuli and/or intracellular cholesterol accumulation. In addition, several modulators of FoxP3 have been identified. Destabilized T regs can develop into distinct phenotypes, which can express several opposing TFs and canonical T-cell cytokines simultaneously: revealed several distinct clusters with mixed T reg , T H 17, and T H 1 phenotypes in mice. In some of these clusters, a supposedly protective while in others a pathogenic gene expression profile dominated. 5 Flow cytometry of human ApoB + T cells has revealed similar phenotypic patterns. 3, 5 In another study, LDL-reactive T cells from a mouse expressing a transgenic TCR directed against LDL/ApoB developed into T FH. These were atheroprotective by inducing antibodies that cleared LDL. 109 It is therefore to assume that ApoB + T cells likely exist in several flavors and functions that range from immunosuppressive to pathogenic phenotypes. It should also be noted that in several pathologies, antigen-specific T regs are prone to mechanisms of plasticity as outlined above. 108 In general, effector functions of T-helper cells in atherosclerosis are manifold: they have the ability to interact with other immune and stromal cells and thereby instruct other leukocytes to promote or inhibit plaque regression, 50 and to secrete pro-or anti-inflammatory cytokines, myeloid cell growth factors, or matrix-destabilizing proteases that can induce an instable plaque phenotype. In addition, they may act immunosuppressive by direct cellular contact inhibition or cytotoxic by granzyme-induced cell death. 111 The exact mechanisms by which ApoB + T cells potentially modulate atherosclerosis, however, are currently unknown.

Several studies employing CyTOF, scRNA-seq, or CITEseq have demonstrated the existence of aortic and plaque-resident T cells that do not express protein or gene transcripts coding for CD4 and CD8 (DNs) or that express both (DPs). 37, 39 It has been speculated that aortic/plaque DP and DN may represent immature T cells (thymocyte-like), 47 but this hypothesis is controversial: In early scRNA-seq studies and a recent meta-analysis, one cluster had a high cluster-wide expression for Cd4, Cd8, and Cd3g/Cd3d which was termed mixed, possibly because of a mix of single-positive Cd4 + and Cd8 + T cells in the same cluster. This cluster accounts for ≈13% to 26% of aortic T cells in mice 39, 46 and expresses high levels of the thymocyte genes coding for TCF1 (Tcf7), Rag-1 (Rag1), and C-C motif chemokine receptor 9 (Ccr9) (Figure 1 ). The existence of DPs (Cd4 + Cd8 + ) on a single cell level, however, was not directly proven in these data sets because of the technical limitations of scRNA-seq described above. In addition, immature DP-thymocytes express only extremely low levels of extracellular TCR-β/CD3-complexes. CyTOF of human lesional T cells, however, detected a cell cluster with surface expression of CD3, CD4, and CD8, 37 which is arguing against a real thymocyte-like phenotype. Interestingly, mature CD3 + CD4 + CD8 + T cells that do not express thymic-stage markers have been identified in cancer tissues 112, 113 and blood of patients with rheumatoid arthritis. 114 CD4 + CD8 + DP aortic T cells may in fact be closer to these peripheral DP cells than to immature (thymic) DP cells.

Other clusters in one CyTOF dataset expressed TCR 39 (in mice) or CD3 37,39 (in humans) at a low level, but not CD4 or, which is suggestive of thymocyte DN-like cells or a chronically activated T cell that has downregulated CD4 or CD8, respectively. 115, 116 In one study, some of these CD4 − CD8 − CD3 + cells additionally expressed the NK cell marker CD56, and CD45RA, which may argue for natural killer T cells 117 rather than for DN T cells. CD4 + CD8 + and CD4 − CD8 − cells could therefore contain several subsets (DP-like, DN-like) with distinct functionality and origin. While some expression patterns argue for immature cells, their exact phenotypes, transcriptomes, and functions are not resolved yet. The most intriguing and controversial question will have to be addressed in future work: Can extrathymic T-cell maturation occur in atherosclerotic plaques?

In contrast to scRNA-seq, which allows screening of the entire transcriptome at the cost of low-expressed genes, high-parametric protein immunophenotyping by CyTOF helps to interrogate phenotypic heterogeneity based on known surface markers. CyTOF was particularly powerful to subdivide human lesional T cells into distinct states of activation, tissue residency, and exhaustion. The predominant differentiation of lesional T cells into activated (antigen-experienced) effector-memory T cells and central-memory cells (CCR7 low CD45RA high CD69 + ) was observed and suggested the existence of tissue-resident memory T cells (T RM ) in the atherosclerotic plaque. 37 T RMs are a unique lineage of T cells that reside in tissues but do not recirculate and thereby provide local tissue protection in infection. CD69 and CD103 are key markers for T RMs , although not all T RMs express these markers. 37, 69 In atherosclerotic plaques, a subcluster of CD8 + T cells coexpressed CD69 + and CD103+0.37 While the exact role of this T-cell subpopulation remains to be defined experimentally, it is intriguing to speculate whether T RMs in atherosclerotic lesions are antigen specific or not: a large body of work has suggested that chronic and acute infection caused by cytomegalovirus, HIV, influenza virus, Chlamydia pneumoniae, 118 and severe acute respiratory syndrome coronavirus 2 119 may directly interfere with the development and progression of atherosclerosis. The indepth evaluation of T RMs may help to better understand potential interactions between pathogens, the healthy vessel wall, and atherosclerotic disease.

Several populations of plaque-resident T cells were detected by CyTOF 37 that express the coinhibitory molecule PD-1 (programmed cell death protein 1), which marks T-cell exhaustion, 120 a state of terminal differentiation, dysfunctionality, and hyporesponsiveness induced by chronic antigen-specific stimulation. 120 PD-1 + cells coexpressed other known markers of T-cell exhaustion: CD57, which indicates terminal differentiation and senescence in T cells, 121 EOMES (eomesodermin), and Lag-3 (lymphocyte-activation gene 3). In mice, the ectonucleotidase CD39 inhibits expression of the effector cytokines TNF-α and IFN-γ in a subset of CD8 + T cells in atherosclerotic aortas. 122 Physiologically, T-cell exhaustion seems to arise from a chronic exposure to autoantigens. Whether this state of dysfunctionality is driving or protecting from atherosclerosis is not entirely clear yet. A genetic deficiency of PD-1 or antibody-mediated blockade of PD-1 increased atherosclerotic lesion size, 123, 124 which is consistent with the clinical observation that cancer patients receiving checkpoint inhibition therapies that block PD-1 and, thus, reverse exhaustion are at an increased risk of atherosclerotic disease. 125 

Preventive concepts for patients with clinical atherosclerosis are currently limited to a modulation of classical risk factors and lipid-lowering strategies, although an increasing body of evidence argues for a role of the immune system and inflammation. 6 High parameter immunophenotyping has proven its ability to identify novel and unexpected candidate markers and mediators of atherosclerosis. For instance, scRNA-seq from human carotid atherosclerosis has surprisingly suggested a predominance of proinflammatory IFN-γ-, IL-12-, and TNF-signaling across different cell types in asymptomatic patients-a finding that contradicts the traditional view that proinflammatory pathways trigger plaque instability and cardiovascular complications. 126 Likewise, pathways associated with IL-1β, a validated therapeutic target in coronary atherosclerosis in the CANTOS trial (Canakinumab Antiinflammatory Thrombosis Outcome Study), 127 were less engaged in T cells from rupture-prone symptomatic carotid plaques. Although these findings may be explained by fundamental differences in carotid versus coronary atherosclerosis or an only partially proatherosclerotic role of IL-1β, 128 more extensive research is required to understand the clinical impact of T-cell diversity in humans.

The translation of murine T-cell immunology remains an ongoing challenge. Basic concepts of T-cell heterogeneity have largely been defined in the mouse with an increasing number of single cell studies in mouse atherosclerosis defined to either describe leukocytes 39, 40, [46] [47] [48] [49] [50] [51] [52] or stromal cells. [42] [43] [44] In contrast, only a limited number of studies exploring single cell phenotypes of T cells in human atherosclerosis is available yet. 37, 45 The latter have established that-in contrast to mice-phenotypic differences in humans are driven mostly by transcriptional programs of activation, exhaustion, and inflammation and not by traditional T H -types. How phenotypes in both species overlap is currently unknown. In addition, human plaques seem to be dominated by T cells, although atherosclerotic plaques from mice contain relatively more macrophages. Beyond differences in fundamental T-cell phenotypes, mechanisms and dynamics of immune cells in mice and humans differ considerably and render the direct comparison difficult. First, T cells in the mouse are generated throughout life, while the production of new T cells in humans ceases over time. This, together with the lack of repetitive infections and a mature microbiome in sterile-housed mice, partially explains the higher degree of exhaustion and activation in human T cells. 129, 130 Second, inbred mouse strains favor certain types of immune responses, which is exemplified by C57BL/6J mice that have a bias toward T H 1 and BALB/C mice that are more likely to elicit T H 2 responses. The genetic background itself has a direct impact on atherosclerosis as recently demonstrated by the hybrid mouse diversity panel. 131 Third, mice represent an ideal model organism to explore peptide specific T-cell responses: common laboratory mouse strains express only one MHC-II variant (eg, I-A b in C57BL/6J mice), which allows direct and feasible in silico screening strategies for potential self-peptides. On the contrary, humans exhibit a considerable variability with over 200 MHC-II alleles that form over 10 000 different functional MHC-II complexes. Because the susceptibility of an autoimmune response against selfpeptides is determined by the capacity of peptides to bind to the MHC-II complex, antigen-specific responses in humans are far more difficult to predict. Only a few studies have validated the existence of ApoB-specific T cells in humans, 3, 5, 110 and it remains elusive whether the sequences and MHC-II affinities of different self-peptides predispose for distinct phenotypes and outcomes in humans. It is now acknowledged that a more finegrained analysis of dynamics, phenotypes, and specificities of atherosclerosis-relevant or ApoB-specific T cells is instrumental to establish novel immunomodulatory strategies for human atherosclerosis in the future.

High-parametric leukocyte analysis of atherosclerotic aortas and plaques has led us to a deeper understanding of leukocyte diversity and activation. Several studies have applied transcriptional, proteomic, and immunologic approaches, often in a combination of these techniques, to describe yet unknown layers of T-cell heterogeneity T in mouse and human atherosclerosis. Together, these studies pinpoint T cells as powerful modulators of plaque associated inflammation: they represent the largest population of viable leukocytes in the plaque, in particular in humans, with a great and largely unexpected phenotypic diversity. Several novel concepts have arisen from these first studies: first, traditional immunologic concepts that are based on T H -lineages fail to describe the actual heterogeneity of T cells in the atherosclerotic plaque that is rather driven by states of activation, exhaustion, development, and inflammation. Second, a substantial proportion of pathogenic T cells stems from regulatory T cells that are highly plastic and have the ability to pass through different T H -lineages. Third, a relevant fraction of CD4 + T cells in the plaque can be considered antigen-specific and recognizes autoantigens such as LDL/ApoB. Ongoing antigen-recognition and TCR-signaling events, and the proinflammatory microenvironment in the plaque, are the likely causes for a unique T-cell phenotype that combines highly flexible pro-and anti-inflammatory attributes at the same time. Fourth, appearance and gene expression of leukocyte populations in the plaque and in the circulation seem to correlate with disease progression. At the same time, the field of high parameter immunophenotyping has just been evolved and many important questions have to be addressed in future work. It is critical to understand which exact stimuli drive the destabilization of T regs and the appearance of pathogenic cell clusters and whether these can be targeted by medical therapies. Therefore, it is required to more precisely link phenotypes to clinical outcomes. The in silico enumeration of functional T-cell clusters in peripheral blood or tissues (liquid biopsies, virtual flow cytometry) 132 holds great promise to establish high-throughput prediction tools. 39 Future immunophenotyping will also have to account for disease-specific tissue gene signatures and the In humans, T cells can be routinely sampled from surgically excised carotid, peripheral arterial atherosclerotic plaques, and peripheral blood. Mass cytometry (cytometry by time of flight [CyTOF]), single cell RNA-sequencing (scRNA-seq), or a combination of antibody-staining and scRNA-seq in cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) have the potential to uncover unique, even rare, cell populations with distinct identities and potentially specialized roles in atherosclerosis (atherosclerosis-specific T cell). The addition of functional layers by staining with tetramers of MHC-II (major histocompatibility complex II) loaded with peptides from autoantigens and with T-cell receptor (TCR) sequencing in a combination with CyTOF or scRNA-seq integrates the cell surface proteome and transcriptome with antigen-specificity. Such integration generates cell type-specific gene signature, which-vice versa-are detectable in silico in bulk RNAsequencing data sets, an approach referred to as RNA-deconvolution, liquid biopsy, or virtual flow cytometry. The correlation with clinical outcome data will be helpful to discover clinically relevant cell types. Their transcriptomes or frequencies in blood or tissue may predict the clinical outcomes or identify novel targets for future immunomodulatory cell therapy. TF indicates transcription factor. Schematics adapted from "Smart Servier Medical Art. "

identification of antigen-specific T cells by MHC-II multimers or TCR-sequencing ( Figure 3 ). Only the detailed understanding of underlying mediators of the inflammatory and immune response will allow us to develop tailored immunomodulatory strategies as atheroprotective vaccination in the future. 

CD4 helper and CD8 cytotoxic T cell differentiation

Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease

Regulatory CD4+ T cells recognize major histocompatibility complex class II molecule-restricted peptide epitopes of apolipoprotein B. Circulation

Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis

Pathogenic autoimmunity in atherosclerosis evolves from initially protective apolipoprotein B100-reactive CD4+ T-regulatory cells

Immunity and inflammation in atherosclerosis

T cell subsets and functions in atherosclerosis

Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines

Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis

CCR5+T-bet+FoxP3+ effector CD4 T cells drive atherosclerosis

T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses

IFN-gamma potentiates atherosclerosis in ApoE knock-out mice

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins

Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/-mice

Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype

Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice

Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice

Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

Transforming growth factor-β signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway

IL-9 aggravates the development of atherosclerosis in ApoE-/-mice

helper cell biology: a decade of discovery and diseases

Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis

STAT4 contributes to adipose tissue inflammation and atherosclerosis

Control of regulatory T cell development by the transcription factor Foxp3

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Natural regulatory T cells control the development of atherosclerosis in mice

Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis

Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia

Atherosclerosis-driven treg plasticity results in formation of a dysfunctional subset of plastic IFNγ+ Th1/Tregs

Functional and homeostatic defects of regulatory T cells in patients with coronary artery disease

Altered status of CD4(+) CD25(+) regulatory T cells in patients with acute coronary syndromes

Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling

Innate and adaptive immune cell subsets as risk factors for coronary heart disease in two population-based cohorts

Hypercholesterolemia induces differentiation of regulatory T cells in the liver

A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice

Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice

Single-cell immune landscape of human atherosclerotic plaques

Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent

Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNAsequencing and mass cytometry

Migratory and dancing macrophage subsets in atherosclerotic lesions

Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversity. Cardiovasc Res

The stem cell pluripotency genes klf4 and oct4 regulate complex smc phenotypic changes critical in late-stage atherosclerotic lesion pathogenesis

Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human

Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vessels

Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics

Single-cell rna-seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis

Meta-analysis of leukocyte diversity in atherosclerotic mouse aortas

Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression

Transcriptome analysis reveals nonfoamy rather than foamy plaque macrophages are proinflammatory in atherosclerotic murine models

Regulatory T cells license macrophage pro-resolving functions during atherosclerosis regression

Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression

Adventitial cell atlas of wt (wild type) and ApoE (apolipoprotein E)-deficient mice defined by single-cell RNA sequencing

Simultaneous epitope and transcriptome measurement in single cells

Precursors of human cd4(+) cytotoxic t lymphocytes identified by single-cell transcriptome analysis

Embracing the dropouts in single-cell RNA-seq analysis

Local proliferation dominates lesional macrophage accumulation in atherosclerosis

Single cell RNA sequencing in atherosclerosis research

Peptide:MHCII tetramer-based cell enrichment for the study of epitope-specific CD4+ T cells

The discovery of cellular immunity in the atherosclerotic plaque

Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque

Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin β receptors

Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses

A change in inflammatory footprint precedes plaque instability: a systematic evaluation of cellular aspects of the adaptive immune response in human atherosclerosis

Spatial transcriptomics coming of age

Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice

Hypercholesterolemia enhances T cell receptor signaling and increases the regulatory T cell population

CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall

Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques

Understanding subset diversity in T cell memory

Quantification of various inflammatory cells in advanced atherosclerotic plaques

Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response

T-cells from advanced atherosclerotic lesions recognize hHSP60 and have a restricted T-cell receptor repertoire

Identification of apob-100 peptide-specific cd8+ t cells in atherosclerosis

CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide

CD8(+) T cells: foot soldiers of the immune system

Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice

Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage death

CD8+ T cells regulate monopoiesis and circulating Ly6C-high monocyte levels in atherosclerosis in mice

T-cells contribute to lesion stabilization in advanced atherosclerosis by limiting macrophage content and CD4+ T-cell responses

Induction of HLA-A2 restricted CD8 T cell responses against ApoB100 peptides does not affect atherosclerosis in a humanized mouse model

Immunization with an ApoB-100 related peptide vaccine attenuates Angiotensin-II induced hypertension and renal fibrosis in mice

Control of the T follicular helper-germinal center B-cell axis by CD8 + regulatory T cells limits atherosclerosis and tertiary lymphoid organ development

Immune regulation by CD8+ Treg cells: novel possibilities for anticancer immunotherapy

The roles of CD8+ T cell subsets in antitumor immunity

The role of chemokine receptors in primary, effector, and memory immune responses

Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule

CD28 costimulation of T helper 1 cells enhances cytokine release in vivo

IL-7 is critical for homeostatic proliferation and survival of naive T cells

RORα in Treg cells

CXCR6 regulates the recruitment of pro-inflammatory IL-17A-producing T cells into atherosclerotic aortas

RORγt+ cells selectively express redundant cation channels linked to the Golgi apparatus

Singular role for T-BET+CXCR3+ regulatory T cells in protection from autoimmune diabetes

FoxP3+RORgammat+ T helper intermediates display suppressive function against autoimmune diabetes

RORγt-expressing tregs drive the growth of colitis-associated colorectal cancer by controlling IL6 in dendritic cells

The microbiota regulates type 2 immunity through RORγt + T cells

Tbet expression in regulatory T cells is required to initiate Th1-mediated colitis

Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis

CD27 co-stimulation increases the abundance of regulatory T cells and reduces atherosclerosis in hyperlipidaemic mice

An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos

Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis

Atherosclerosis and interferon-γ: new insights and therapeutic targets

Interferon-γ drives treg fragility to promote anti-tumor immunity

Hypoxia in atherosclerosis and inflammation

Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1

The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3

Stability and maintenance of Foxp3+ treg cells in non-lymphoid microenvironments

Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response

Low-density lipoprotein-reactive T cells regulate plasma cholesterol levels and development of atherosclerosis in humanized hypercholesterolemic mice

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

Differentiation of effector CD4 T cell populations (*)

CD4+/CD8+ doublepositive T cells: more than just a developmental stage?

Double positive CD4+CD8+ T cells are enriched in urological cancers and favor T helper-2 polarization

Peripheral CD4CD8 double positive T cells with a distinct helper cytokine profile are increased in rheumatoid arthritis

Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation

Helper T cells downregulate CD4 expression upon chronic stimulation giving rise to double-negative T cells

Tissue-specific functions of invariant natural killer T cells

Infections, atherosclerosis, and coronary heart disease

COVID-19 and cardiovascular disease

Defining 'T cell exhaustion

Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells

CD39 identifies a microenvironment-specific anti-inflammatory CD8+ T-cell population in atherosclerotic lesions

Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation

Programmed cell death-1 deficiency exacerbates T cell activation and atherogenesis despite expansion of regulatory T cells in atherosclerosis-prone mice

Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease

Plaque stabilization: can we turn theory into evidence?

Antiinflammatory therapy with canakinumab for atherosclerotic disease

Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice

Normalizing the environment recapitulates adult human immune traits in laboratory mice

Laboratory mice born to wild mice have natural microbiota and model human immune responses

The hybrid mouse diversity panel: a resource for systems genetics analyses of metabolic and cardiovascular traits

Robust enumeration of cell subsets from tissue expression profiles

None.